Jump to navigation
Industry News
- 05/12/08Duke Spinout Argos Advances HIV Therapy Trials
- Durham's Argos Therapeutics enters Phase 2a clinical trial on its RNA-based HIV treatment.
- 05/08/08Quintiles Transnational to Buy Eidetics
- Quintiles Transnational will add to its fast-growing consulting business after signing an agreement to purchase Boston-based Eidetics. Durham-based Quintiles, the world's largest clinical research organization, didn't disclose the terms of the deal, which the privately held company said is subject...
- 05/08/08UNC Picks Thorp to Be Chancellor
- Holden Thorp, an acclaimed chemistry professor and dean at the University of North Carolina at Chapel Hill who also has made his mark with several businesses, will be the next UNC chancellor. Thorp, chair of the department of chemistry and...
- 05/08/08BDSI's Pain Patch Does Well in Human Trial
- The pain patch on which BioDelivery Sciences International has bet its future came up a winner in its latest round of human testing, the Raleigh drug company said Thursday. BDSI (Nasdaq: BDSI) on Thursday reported positive phase III trails results...
- 05/08/08SEBIO Announces Semi-Finalists for Competition
- Two North Carolina technologies are among the 10 chosen as semi-finalists for Southeast BIO's BIO/Plan Competition.
- 05/07/08ConvaTec Sold to New Owners for $4.1 billion
- Bristol-Myers Squibb gets $4.1 billion from the sale of ConvaTec. The maker of wound and ostomy products has 400 employees in Greensboro.
- 05/07/08Duke, FDA Experts Lead Clinical Trials Group
- Duke-led coalition co-founded by FDA to improve clinical trials process names 12-member executive board.
- 05/06/08ParagonDx Gets FDA OK For Warafin Test
- ParagonDx, a genetic and molecular testing diagnostics company based in Morrisville, N.C., has received clearance from the FDA to market its in vitro diagnostic test for warfarin sensitivity. Warafin is a blood thinner that prevents and treats blood clots.
- 05/06/08Targacept Decision Triggers Milestone Payment
- The Winston-Salem company has named the lead compound for its smoking cessation research program. The decision earned Targacept a $500,000 milestone payment from GlaxoSmithKline.
- 05/06/08Cornerstone Acquiring Critical Therapeutics
- Cornerstone BioPharma is planning an acquisition merger with Boston's Critical Therapeutics. The merger will create a new publicly traded company, Cornerstone Therapeutics, with headquarters in Cary.
- 04/29/08Pozen Announces Milestone Payment
- Pozen, Inc., receives $20 million in milestone payments from GlaxoSmithKline (GSK) for the U.S. Food and Drug Administration (FDA) approval of, and GSK's intent to commercialize, the migraine drug Treximet(TM). GSK will also manufacture the drug.
- 04/29/08CivaTech Oncology Gets $1M Series B Funding
- Anti-Cancer Device Firm CivaTech Oncology Gets Million-Dollar Boost
- 04/29/08FDA Approves TranS1's Back Surgery System
- TranS1, Inc. receives FDA approval to market its AxiaLIF 2L system - a minimally invasive surgical approach to treat degenerative disc disease in the lower lumbar region.
- 04/28/08Tryton Medical Relocates to RTP
- Tryton Medical Moves to Research Triangle Park and announces new president.
- 04/25/08Entegrion Gets FDA OK for Blood-Clotting Bandage
- Consumer use of Entegrion blood-clotting bandage gets FDA nod
- 04/23/08Durham's Argos Therapeutics Gets $35.2M Infusion
- Argos Secures $35.2M Financing to Pursue Product Candidates
- 04/23/08Aldagen Lands $18.4M In New Venture Capital
- Aldagen of Durham lands $18.4M in new funding as clinical trials proceed
- 04/21/08UNC, Hamner Institutes Announce Partnership
- The University of North Carolina at Chapel Hill and The Hamner Institutes for Health Sciences have signed a collaborative agreement to accelerate basic, translational research.
- 04/21/08AlphaVax Reports Positive Trial Data
- AlphaVax, Inc., has reported initial positive results from a Phase I clinical trial of a vaccine to treat cytomegalovirus (CMV).
- 04/17/08Wake Forest Regenerative Medicine Group Shares $42.5M Grant to Fight Battle Wounds
- Regenerative Medicine Project Directed at Battlefield Injuries
All Industry News »
